WO1987005300A2 - Protein preservation - Google Patents
Protein preservation Download PDFInfo
- Publication number
- WO1987005300A2 WO1987005300A2 PCT/GB1987/000143 GB8700143W WO8705300A2 WO 1987005300 A2 WO1987005300 A2 WO 1987005300A2 GB 8700143 W GB8700143 W GB 8700143W WO 8705300 A2 WO8705300 A2 WO 8705300A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polyhydroxy compound
- water
- protein
- process according
- haemoglobin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Definitions
- the present invention relates to a method of dry storage which now permits the long-term preservation of materials such as haemoglobin, erythrocyes, liposomes and cells.
- Oxidation of the iron atom of the haem prosthetic group from 2+ to the 3+ state converts oxy- or deoxyhaemoglobin to the biologically nonfunctional methaemoglobin.
- the reaction is promoted by conditions of low oxygen tension and is minimised i n vivo by the presence of potent reducing systems operating in the cytoplasm of intact erythrocytes.
- erythrocytes are obtained from human donors for transfusion, their storage ex vivo is limited, in part, by the accelerated formation of oxidised haem (methaemoglobin).
- the present invention therefore provides a process for preserving a material having a water-dependant structure comprising contacting the material with an aqueous solution of a polyhydroxy compound then removing water from the material.
- material having a water-dependant structure it is intended to encompass such materials as proteins, liposomes and cells which have secondary, tertiary or quaternary structure determined by hydrophobic and/or hydrophilic interactions in the presence of water which structure is irreversibly altered or partially or completely destroyed by removal of the water.
- polyhydroxy compound it is intended to encompass any material having two or more hydroxy groups per molecule which is capable of hydrogen bonding to, or otherwise stabilising, a material having a water-dependant structure.
- Suitable polyhydroxy compounds include sugars and similar or related polyols, especially trioses, pentoses and hexoses, mono-, di or oligosaccharides and related polyols.
- Preferred polyhydroxy compounds are glucose, galactose and non-reducing sugars especially trehalose.
- the present invention in a particular embodiment also provides a process for preserving a material having a water-dependant structure which encapsulates one or more spaces containing aqueous solutions or suspensions which comprises contacting the material with, and introducing into one or more encapsulated spaces therein, an aqueous solution of polyhydroxy compound then removing water from the material.
- the present invention in another aspect provides a dry formulation comprising a material having a water-dependant structure and a polyhydroxy compound.
- the polyhydroxy compound will be in intimate admixture with the material having a water-dependant structure and, in the case where the material encapsulates one or more spaces containing the residue of aqueous solutions or suspensions, preferably the polyhydroxy compound is also dispersed within those spaces.
- the preservation process of the present invention is particularly suitable for the storage of haemoglobin with minimal oxidation of the heme-iron and with retention of gas-transporting capacity upon rehydration.
- the dry haemoglobin may be prepared from simple aqueous solutions of purified haemoglobin, from erythrocyte lysates, from intact erythrocytes or from erythrocyte surrogates (haemosomes).
- Hydrophobic structures such as the membranes which delimit all cells and their organelles, arise by the expulsion of water from their non-polar parts.
- Hydrophilic structures such as globular proteins are stabilised by hydrogen-bonding with water in solution and by the maintenance of specific dipoles in a medium of specific dielectric constant.
- anhydrobiosis In recent years the ability to survive desiccation, now termed “anhydrobiosis”, has been shown to be a property of a small but diverse group of organisms including fungal spores, macrocysts of the slime mold Dictyostelium, baker's yeast, brine shrimp cysts, nematodes and plant seeds (for review see Crowe and Crowe, 1984) .
- Trehalose a non-reduc ing d isacchar ide of glucose that is distributed widely in nature, has been found at particularly high concentrations (as much as 20% of the dry weight) in several of the organisms capable of anhydrobiosis.
- the survival of dehydration by some organisms is correlated with the synthesis of trehalose during dehydration (Madin and Crowe, 1975) or its degradation following rehydration (Clegg. 1964).
- This molecule was implicated in the "water replacement hypothesis", which suggested that the hydroxyl groups of simple carbohydrates might replace the hydration shell of the polar head groups of phosopholipids that is lost during dehydration (Crowe and Clegg, 1973) .
- a particularly novel extension of our invention concerns the stabilisation of dehydrated cells and their surrogates. It is possible to transiently produce pores in both biological and artificial membrane which spontaneously reseal. During the time course of their existence. however, these pores are of sufficient diameter to permit the entry of carbohydrates into the cytoplasm (cells) or encapsulated volume (liposomes). Thus, it should be possible to introduce trehalose (or other carbohydrates) into the cytoplasm of human erythrocytes, enabling their extended storage in the dehydrated state. Autologous red cells could therefore be stored indefinitely for patients at high risk of anaemia. Similarly, haemosomes could be prepared and stored in bulk following dehydration. Application of dry haemosomes would be a simple matter following their rehydration ad hoc.
- Fig. 1 is a histogram showing Percentages of methaemoglobin formed upon rehydration of haemoglobin powders. Sugars were present at concentrations of 0.25 molar following rehydration; haemoglobin was 0.015 molar.
- Oxyhaemoglobin without sugar 2) Deoxyhaemoglobin without sugar, and 3) to 11) Oxyhaemoglobin with 3) Arabinose, 4) Glactose, 5) Fucose, 6) Glucose, 7) Mannose, 8) Maltose, 9) lactose, 10) Trehalose and 11) Sucrose.
- Carbohydrate-protein mixtures were prepared in solution by addition of carbohydrate to the protein dissolved in water or buffer. A variety of trioses, pentoses and hexoses were examined as well as mono- and disacchar ides. Concentrations of the sugars were varied, from 1:1 (weightrweight) up to a maximum of 0.25 molar sugar.
- Water was removed by one of three methods: a) evaporation, in which the solution is mildly heated under a steady stream of gaseous nitrogen; b) evacuation, in which the sample is exposed to reduced pressure at room temperature, or, c) lyophilisation, in which the solution is first frozen in liquid nitrogen and the water sublimed under high vacuum. Dried samoles were stored for extended period over phosphorus pentoxide in vacuo.
- Calorimetric evaluation was performed by differential scanning calorimetry (DSC) using Perkin-Elmer DSC-2.
- the heating rate was 2.5°C/minute and a full-scale deflection on the recorder corresponded to a change in heat flow of 0.25m.cal./sec.
- the transition temperatures obtained were the temperatures of maximal heat flow.
- Table 1 contains the denaturation temperatures and denaturation enthalpy and entropy changes of lysozyme dissolved in water and in solutions of either of the sugars glucose, galactose or trehalose.
- the presence of any of the three sugars increases the denaturation temperature, in general agreement with the observations reported by others (Gerlsma, 1968; Neucere and St. Angelo, 1972).
- the sugars stabilise the native structure of the protein with respect to the denatured state. This property is exhibited by each of the three sugars examined.
- the temperatures of maximum heat flow and the enthalpy and entropy changes associated with the transitions for freeze-dried lysozyme in the presence or absence of carbohydrate are outlined in Table 2.
- the endothermic transition of pure dry lysozyme occurs at a temperature approximately 70°C above the denaturation temperature of the protein in water. In the solid state the polypeptide chains of a protein will be less flexible than in solution at the same temperature.
- a dry protein will reach the degree of flexibility necessary for unfolding of the protein structure at a higher temperature than a protein in aqueous solution.
- each of the carbohydrates tested was capable of protecting haemoglobin against oxidative damage.
- the protective effect was clearly manifest even in those samples that had been stored in the dried state for periods in excess of three months.
- Rehydrated sugar-haemoglobin mixtures were capable of reversible gas exchange as evidenced by the spectral shifts induced by exposure to oxygen, nitrogen or carbon monoxide.
Abstract
A process for preserving a material having water-dependant structure comprising contacting the material with an aqueous solution of a polyhydroxy compound then removing water from the material.
Description
PROTEIN PRESERVATION
The present invention relates to a method of dry storage which now permits the long-term preservation of materials such as haemoglobin, erythrocyes, liposomes and cells.
Oxidation of the iron atom of the haem prosthetic group from 2+ to the 3+ state converts oxy- or deoxyhaemoglobin to the biologically nonfunctional methaemoglobin. The reaction is promoted by conditions of low oxygen tension and is minimised i n vivo by the presence of potent reducing systems operating in the cytoplasm of intact erythrocytes. When erythrocytes are obtained from human donors for transfusion, their storage ex vivo is limited, in part, by the accelerated formation of oxidised haem (methaemoglobin).
Storage in the dry state limits hydrolysis and prevents some of the oxidative damage that can destroy chemical or biological activity. When dealing with biological macromolecules, however, water removal can irreversibly alter secondary, tertiary or quaternary structures and thereby eliminate biological efficacies.
Dehydration of biological membranes is usually accompanied by irrevocable loss of structural and functional integrity (Crowe, Crowe and Jackson, 1983). Upon rehydration of biological membranes morphological
damage is apparent in the redistribution of intramembraneous particles and the fusion between membranes. Moreover, in those membrane systems that are associated with a specific enzyme activity (such as the transport of Ca++) , rehydration induces a complete loss of activity.
Artificial membrane systems prepared by dispersion of phospholipids in aqueous solutions, have received much attention because of their utility in basic research and their potential applications in biotechnology. Dispersions of phospholipids spontaneously form sealed structures called liposomes - the encapsulated volume within a liposome enables the liposome to function as a pharmacological "capsule" or artificial cell. Among the solutes that have been encaosulated in liposomes is human haemoglobin. The "haemosomes" so generated hold much utilitarian promise as erythrocyte surrogates (Djordjevich and Miller, 1980; Gaber et al., 1983; Hayward et al., 1985) . However when liposomes containing entrapped solutes are subjected to dehydration/rehydration, the solutes are lost to the bulk solution (Madden et al., 1985).
The effect of encapsulation of haemoglobin within a phospholipid liposome was to catalyze the oxidation of haemoglobin upon rehydration. No oxyhaemoglobin could be regenerated from rehydrated haemosomes. Moreover, much of the visible absorbance of the rehydrated samples was bleached, resulting in essentially colourless samples.
These observations are similar to those described by Szebeni et al. (1985), who found that unsaturated phospholipids promoted haemoglobin oxidation and were capable of extracting the haem away from the globin portion of the molecule.
We have found that by drying proteins from aqueous solutions containing saccharides, chemical and physical degradative processes can be avoided. If the carbohydrate selected is itself a solid, then a compact, solid protein-carbohydrate mixture is obtained which can be repeatedly cooled below 0ºC and warmed to room temperature without diminishing enzyme activity. Moreover this technique may be extended to facilitate storage of other materials having water-dependant structure such as liposomes and even intact cells.
We have examined the ability of trehalose and other sugars to preserve after dehydration/rehydration the biological activity of isolated proteins, protein systems, biological and artificial membranes, and whole cells.
The present invention therefore provides a process for preserving a material having a water-dependant structure comprising contacting the material with an aqueous solution of a polyhydroxy compound then removing water from the material.
By "material having a water-dependant structure" it is intended to encompass such materials as proteins, liposomes and cells which have secondary, tertiary or
quaternary structure determined by hydrophobic and/or hydrophilic interactions in the presence of water which structure is irreversibly altered or partially or completely destroyed by removal of the water.
By "polyhydroxy compound" it is intended to encompass any material having two or more hydroxy groups per molecule which is capable of hydrogen bonding to, or otherwise stabilising, a material having a water-dependant structure. Suitable polyhydroxy compounds include sugars and similar or related polyols, especially trioses, pentoses and hexoses, mono-, di or oligosaccharides and related polyols. Preferred polyhydroxy compounds are glucose, galactose and non-reducing sugars especially trehalose.
The present invention, in a particular embodiment also provides a process for preserving a material having a water-dependant structure which encapsulates one or more spaces containing aqueous solutions or suspensions which comprises contacting the material with, and introducing into one or more encapsulated spaces therein, an aqueous solution of polyhydroxy compound then removing water from the material.
The present invention in another aspect provides a dry formulation comprising a material having a water-dependant structure and a polyhydroxy compound. The polyhydroxy compound will be in intimate admixture with the material having a water-dependant structure and, in the
case where the material encapsulates one or more spaces containing the residue of aqueous solutions or suspensions, preferably the polyhydroxy compound is also dispersed within those spaces.
The preservation process of the present invention is particularly suitable for the storage of haemoglobin with minimal oxidation of the heme-iron and with retention of gas-transporting capacity upon rehydration. The dry haemoglobin may be prepared from simple aqueous solutions of purified haemoglobin, from erythrocyte lysates, from intact erythrocytes or from erythrocyte surrogates (haemosomes).
Whilst not wishing to be bound by any theory it is postulated that the stabilisation afforded according to the present invention may be related to that observed in certain instances of "anhydrobiosis".
The organisation of many biological structures depends absolutely upon the presence of water. Hydrophobic structures, such as the membranes which delimit all cells and their organelles, arise by the expulsion of water from their non-polar parts. Hydrophilic structures such as globular proteins are stabilised by hydrogen-bonding with water in solution and by the maintenance of specific dipoles in a medium of specific dielectric constant.
Some organisms, however, possess a remarkable capacity to survive near-total dehydration, and they may exist in the dehydrated states for periods measured in
years. This fact was recognised as long ago as the year 1800 when it was found that in a dried state tardigrades, small sand-living organisms, were able to withstand temperatures well below freezing and as hot as boiling water (Crowe and Clegg, 1973 and 1978). Normal metabolic processess resumed in these organisms within thirty minutes of their rehydration even after decades of dry storage.
In recent years the ability to survive desiccation, now termed "anhydrobiosis", has been shown to be a property of a small but diverse group of organisms including fungal spores, macrocysts of the slime mold Dictyostelium, baker's yeast, brine shrimp cysts, nematodes and plant seeds (for review see Crowe and Crowe, 1984) .
Trehalose, a non-reduc ing d isacchar ide of glucose that is distributed widely in nature, has been found at particularly high concentrations (as much as 20% of the dry weight) in several of the organisms capable of anhydrobiosis. The survival of dehydration by some organisms is correlated with the synthesis of trehalose during dehydration (Madin and Crowe, 1975) or its degradation following rehydration (Clegg. 1964). This molecule was implicated in the "water replacement hypothesis", which suggested that the hydroxyl groups of simple carbohydrates might replace the hydration shell of the polar head groups of phosopholipids that is lost during dehydration (Crowe and Clegg, 1973) .
Recent experiments using infrared spectroscopy
(Crowe, Crowe and Chapman, 1984), have provided evidence that trehalose may substitute for water by forming hydrogen bonds with the head groups of phospholipid bilayers thereby stabilising membrane structure in the absence of water. Support for this model was obtained by Madden et al. (1985) who demonstrated that the integrity of unilamellar liposomes is retained (i.e. no leakage of solute from the internal aqueous compartment of the liposome) if dehydration is carried out in the presence of carbohydrate. This protective capacity was shared among all of the carbohydrates tested.
Sugars and similar poly alcohols have been utilised in solution to preserve enzymatic activities (Bradbury and Jakoby, 1972) , inhibit irreversible aggregation (Frigon and Lee, 1972) and increase the temperature at which proteins are thermally denatured (Gerlsma, 1968; Neucere and St. Angelo, 1972).
Due to the widespread use of proteins in analytical, synthetic and biological chemistry, we envisage that carbohydrate-mediated protection of dried proteins will have many applications. The storage stability of most proteins should be enhanced by the processes we describe.
A particularly novel extension of our invention concerns the stabilisation of dehydrated cells and their surrogates. It is possible to transiently produce pores in both biological and artificial membrane which spontaneously reseal. During the time course of their existence.
however, these pores are of sufficient diameter to permit the entry of carbohydrates into the cytoplasm (cells) or encapsulated volume (liposomes). Thus, it should be possible to introduce trehalose (or other carbohydrates) into the cytoplasm of human erythrocytes, enabling their extended storage in the dehydrated state. Autologous red cells could therefore be stored indefinitely for patients at high risk of anaemia. Similarly, haemosomes could be prepared and stored in bulk following dehydration. Application of dry haemosomes would be a simple matter following their rehydration ad hoc.
The invention will now be illustrated by non-limiting Examples and with reference to the accompanying drawings in which; Fig. 1 is a histogram showing Percentages of methaemoglobin formed upon rehydration of haemoglobin powders. Sugars were present at concentrations of 0.25 molar following rehydration; haemoglobin was 0.015 molar. 1) Oxyhaemoglobin without sugar, 2) Deoxyhaemoglobin without sugar, and 3) to 11) Oxyhaemoglobin with 3) Arabinose, 4) Glactose, 5) Fucose, 6) Glucose, 7) Mannose, 8) Maltose, 9) lactose, 10) Trehalose and 11) Sucrose.
EXAMPLES 1 AND 2
Different sugars are utilised to produce dry powders of two separate proteins, chicken egg-white
lysozyme (Example 1) and human haemoglobin (Examole 2) . Structural stability was examined by calorimetry of the wet and dry lysozyme preparations. Functional stability was verified by spectroscopic evaluation of gas transport by haemoglobin.
Carbohydrate-protein mixtures were prepared in solution by addition of carbohydrate to the protein dissolved in water or buffer. A variety of trioses, pentoses and hexoses were examined as well as mono- and disacchar ides. Concentrations of the sugars were varied, from 1:1 (weightrweight) up to a maximum of 0.25 molar sugar.
Water was removed by one of three methods: a) evaporation, in which the solution is mildly heated under a steady stream of gaseous nitrogen; b) evacuation, in which the sample is exposed to reduced pressure at room temperature, or, c) lyophilisation, in which the solution is first frozen in liquid nitrogen and the water sublimed under high vacuum. Dried samoles were stored for extended period over phosphorus pentoxide in vacuo.
Calorimetric evaluation was performed by differential scanning calorimetry (DSC) using Perkin-Elmer DSC-2. The heating rate was 2.5°C/minute and a full-scale deflection on the recorder corresponded to a change in heat flow of 0.25m.cal./sec. The transition temperatures obtained were the temperatures of maximal heat flow.
Table 1 contains the denaturation temperatures
and denaturation enthalpy and entropy changes of lysozyme dissolved in water and in solutions of either of the sugars glucose, galactose or trehalose. The presence of any of the three sugars increases the denaturation temperature, in general agreement with the observations reported by others (Gerlsma, 1968; Neucere and St. Angelo, 1972). Hence, in solution, the sugars stabilise the native structure of the protein with respect to the denatured state. This property is exhibited by each of the three sugars examined.
The temperatures of maximum heat flow and the enthalpy and entropy changes associated with the transitions for freeze-dried lysozyme in the presence or absence of carbohydrate are outlined in Table 2. The endothermic transition of pure dry lysozyme occurs at a temperature approximately 70°C above the denaturation temperature of the protein in water. In the solid state the polypeptide chains of a protein will be less flexible than in solution at the same temperature.
Therefore, a dry protein will reach the degree of flexibility necessary for unfolding of the protein structure at a higher temperature than a protein in aqueous solution.
In the presence of sugar, the transition temperature is decreased, and the enthalpy and entropy changes for the transition equal or exceed those values seen for the protein in solution. Thus, it is apparent that as the water of hydration is removed from the surface of the protein, it is gradually replaced by sugar, resulting in a stabilisation of protein conformation that does not occur in the absence of added sugar.
Although each of the three sugars studied was capable of restoring the calorimetric behaviour of dissolved lysozyme to the dried protein, it was observed that the heated powders containing glucose or galactose were "browned". This browning reaction did not occur in the presence of trehalose. Thus, the selective pressure toward the occurrence of trehalose in anhydrobiotic organisms may be due less to its capcity to substitute for water than to its non-reducing characteristics which prevent the browning reaction. Nonetheless, in our invention any of the above-mentioned sugars are appropriate for storage of dry protein-sugar mixtures.
These results were extended by determinations of the functional integrity of a human haemoglobin before and after dehydration/rehydration in the presence or absence of various carbohydrates. The relative concentrations of oxy-, deoxy- and methaemoglobins were calculated from the spectra obtained in solution according to the methods described in Benesch et al. (1965).
In Figure 1 are presented the percentages of methaemoglobin formed in solutions of human haemoglobin following a cycle of dehydration/rehvdration. When dried haemoglobin without sugar was rehydrated, the solution assumed the brown colour characteristic of methaemoglobin. The percentage of methaemoglobin formed increased with the duration of storage, up to 90% of the total haem. Similar spectra could be generated by catalytic oxidation of the haem after addition of potassium ferricyanide.
In strong contrast to the behaviour of rehydrated haemoglobin in the absence of sugar, each of the carbohydrates tested was capable of protecting haemoglobin against oxidative damage. The protective effect was clearly manifest even in those samples that had been stored in the dried state for periods in excess of three months. Rehydrated sugar-haemoglobin mixtures were capable of reversible gas exchange as evidenced by the spectral shifts induced by exposure to oxygen, nitrogen or carbon monoxide.
Together, our results obtained with dried powders of lysozyme or haemoglobin demonstrate that carbohydrates enhance the stability of anhydrous proteins and permit the retention of physicochemical and biological activities after rehydration.
EXAMPLE 3
Our previous investigations of hemosomes as erythrocyte surrogates (Hayward et al., 1985) in
combination with our demonstration of protein stabilisation in the dry state by carbohydrate, prompted us to examine the capacity of sugars to stabilize artificial red blood cells in the dry state. We reasoned that the protective capacity of carbohydrate in this instance should be bimodal - prevention of the oxidation and denaturation of haemoglobin and the simultaneous retention of encapsulated haemoglobin within the internal aqueous compartment of the haemosome.
We found that inclusion of carbohydrates (both within the haemosome and in the external, bulk solution) prevented haem oxidation. Furthermore, rehydrated carbohydrate/haemosomes could be passed through a molecular sieve without diminution in the ratio of haemoglobin: phospholipid. All of the carbohydrates tested to-date have been effective in this capacity. Conversely, carbohydrate-free haemosomes became irreversibly aggregated and the phospholipid was readily separated from haemoglobin due to the former's relative buoyancy.
LITERATURE CITED
Benesch, R. , MacDuff, G. and Benesch, R.E/ (1965) Anal Biochem 11: 81 - 87.
Bradbury, S.L. and Jakoby, W.B. (1972) Glycerol as an enzyme-stabilizing agent: effects on aldehyde dehydrogenase, Proc. Nat Acad Sci 69: 2373 - 2376.
Clegg, J.S. (1964) The control of emergence and metabolism by external osmotic pressure and the role of free glycerol in developing cysts of Artneia salina, J. Exp Biol 41 : 879 - 892.
Crowe, J.H. and Clegg, J.S. (1973) "Anhydrobiosis:, Dowden, Hutchinson and Ross, Stroudsburg, P.A. p. 473. Crowe, J.H, and Clegg, J.S. (1978) "Dry Biological Systems", Academic Press, NY, p. 357. Crowe, J.H, Crowe, L.M. and Jackson S.A. (1983) Preservation of structural and functional activity in lyophilised sarcoplasmic reticulum. Arch Biochem Biophys. 220: 477 - 484.
Crowe, L.M. and Crowe, J.H. (1984) Effects of dehydration on membranes and membrane stabilisation at low water activities, in Chapman, D. , ed., "Biological Membranes", Volume 5, Academic Press, London, pp. 57 - 102. Crowe J.H., Crowe, L.M. and Chapman, D. (1984) Preservation of membranes in anhydrobiotic organisms: the role of trehalose. Science 223: 701 - 703. Djordjevich, L. and Miller, I.F. (1980) Synthetic erythrocytes from lipid encapsulated hemoglobin, Exp. Hematol. 8: 584 -592.
Frigon, R.P. and Lee, J.C. (1972) The stabilization of calf-brain microtubule protein by sucrose. Arch. Biochem Biophys 153: 587 - 589.
Gaber , B., Yager, P., Sheridan, J.P. and Chang, E.L,. (1983) Encapsulation of hemoglobin in phospholipid
vesicles, FEBS Lett. 153: 285 - 288. Gerlsma, S.Y. (1968) J. Biol Chem 243: 957 - 963. Hayward, J.A. Levine, D.M., Neufeld, L. , Simon, S.R. , Johnston, D.S. and Chapman D. (1985) Polymerized liposomes as stable oxygen-carriers, FEBS Lett 187: 261 - 266. Madden, T.D., Bally, M.B., Hope, M.J., Cullis, P.R., Schieren, H.P. and Janoff, A.S. (1985) Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicles contents, Biochem. Biophys Acta 817: 67 - 74.
Madin, K.A.C. and Crowe, J.H. (1975) Anhydrobiosis in nematodes: carbohydrate and lipid metabolism during dehydration. J. Exp. Zool. 193: 335 - 342. Neucere, N.J. and St. Angelo, A.J. (1972) Physicochemical properties of peanut proteins in sucrose. Anal Biochem. 47: 80 - 89.
Szebeni, J., Di Iorio, E.E., Hauser, H. and Winterhalter, K.H. (1985) Encapsulation of hemoglobin in phospholipid vesicles: characterization and stability. Biochemistry 24: 2827 - 2832.
Claims
1. A process for preserving a material having water-dependant structure comprising contacting the material with an aqueous solution of a polyhydroxy compound then removing water from the material.
2. A process according to claim 1 wherein the material is a protein, liposome or cell.
3. A process according to claim 1 wherein the material is an erythrocyte, oxyhaemaglobin, deoxyhaemaglobin or liposomes encapsulating oxyhaemaglobin or deoxyhaemaglonin.
4. A process according to claim 1 wherein the material encapsulates one or more spaces containing aqueous solutions or suspensions and wherein the process comprises contacting the material with, and introducing into one of more encapsulated spaces therein, an aqueous solution of a polyhydroxy compound then removing water from the material.
5. A process according to claim 1 wherein the polyhydroxy compound is a sugar or related polyol.
6. A process according to claim 5 wherein the polyhydroxy compound is selected from trioses, pentoses, hexoses, mono-, di- or oligosaccharides and related polyols.
7. A process according to claim 6 wherein the polyhydroxy compound is selected from glucose, galactose and non-reducing sugars.
8. A process according to claim 7 wherein the polyhydroxy compound is trehalose.
9. A dry formulation comprising a material having a water-dependant structure and a polyhydroxy compound in intimate admixture therewith.
10. A formulation according to claim 9 wherein the material is a protein, liposome or cell.
11. A formulation according to claim 9 wherein the material is an erythrocyte, oxyhaemaglobin, deoxyhaemaglobin or liposomes encapsulating oxyhaemaglobin or deoxyhaemaglobin.
12. A formulation according to claim 9 wherein the material encapsulates one or more spaces containing aqueous solutions or suspensions.
13. A formulation according to claim 9 wherein the polyhydroxy compound is a sugar or related polyols.
14. A formulation according to claim 13 wherein the polyhydroxy compound is selected from trioses, pentoses, hexoses, mono-, di- or oligosaccharides and related polyols.
15. A formulation according to claim 14 wherein the polyhydroxy compound selected from glucose, galactose and non-reducing sugars.
16. A formulation according to claim 15 wherein the polyhydroxy compound is trehalose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8604983 | 1986-02-28 | ||
| GB868604983A GB8604983D0 (en) | 1986-02-28 | 1986-02-28 | Protein preservation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1987005300A2 true WO1987005300A2 (en) | 1987-09-11 |
| WO1987005300A3 WO1987005300A3 (en) | 1987-10-22 |
Family
ID=10593832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB1987/000143 WO1987005300A2 (en) | 1986-02-28 | 1987-02-27 | Protein preservation |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0259425A1 (en) |
| JP (1) | JPS63502592A (en) |
| GB (1) | GB8604983D0 (en) |
| WO (1) | WO1987005300A2 (en) |
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990004329A1 (en) * | 1988-10-20 | 1990-05-03 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
| WO1990011069A1 (en) * | 1989-03-20 | 1990-10-04 | Parfums Christian Dior | Process for the preparation of a ligand-receptor complex |
| EP0391444A2 (en) * | 1989-04-07 | 1990-10-10 | Syntex (U.S.A.) Inc. | Interleukin-1 Formulation |
| US5030560A (en) * | 1988-11-04 | 1991-07-09 | Immucor, Inc. | Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same |
| EP0448146A1 (en) * | 1990-03-20 | 1991-09-25 | Akzo Nobel N.V. | Stabilized gonadotropin containing preparations |
| US5149653A (en) * | 1988-01-21 | 1992-09-22 | Quadrant Bioresources Limited | Preservation of viruses |
| US5192663A (en) * | 1988-11-04 | 1993-03-09 | Immucor, Inc. | Article having an organic dye and a monolayer of dried mammalian cells and a method for utilizing the article |
| US5270057A (en) * | 1990-03-20 | 1993-12-14 | Akzo N.V. | Stabilized gonadotropin containing preparations |
| WO1994019020A1 (en) * | 1993-02-23 | 1994-09-01 | Genentech, Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| EP0615747A1 (en) | 1993-03-18 | 1994-09-21 | Terumo Kabushiki Kaisha | Hemoglobin-encapsulating liposome and method for making the same |
| US5384132A (en) * | 1990-03-20 | 1995-01-24 | Akzo N.V. | Stabilized gonadotropin containing preparations |
| EP0687463A1 (en) * | 1994-06-15 | 1995-12-20 | Terumo Kabushiki Kaisha | Hemoglobin-encapsulated liposome |
| US5641637A (en) * | 1991-01-11 | 1997-06-24 | Cobe Laboratories, Inc. | Method of preparing lyophilized and frozen cell standards |
| US5648206A (en) * | 1988-08-26 | 1997-07-15 | Cobe Laboratories, Inc. | Lyophilization of cells |
| WO1998034478A1 (en) * | 1997-02-07 | 1998-08-13 | Quadrant Holdings Cambridge Limited | Methods and compositions for producing dried, storage-stable platelets |
| US5800978A (en) * | 1992-01-21 | 1998-09-01 | Cobe Laboratories, Inc. | Method of freezing cells and cell-like materials |
| EP0541556B1 (en) * | 1990-05-14 | 1998-09-16 | Quadrant Holdings Cambridge Limited | Stabilization of biological macromolecular substances and other organic compounds |
| US5817334A (en) * | 1988-10-05 | 1998-10-06 | Nexstar Pharmaceuticals, Inc. | Method of making liposomes with improved stability during drying |
| US5958670A (en) * | 1988-05-18 | 1999-09-28 | Cobe Laboratories, Inc. | Method of freezing cells and cell-like materials |
| US6071428A (en) * | 1995-04-28 | 2000-06-06 | Inhale Therapeutic Systems | Stable compositions |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| US6426210B1 (en) | 1991-06-26 | 2002-07-30 | Inhale Therapeutic Systems, Inc. | Storage of materials |
| USRE37872E1 (en) | 1989-02-16 | 2002-10-08 | Inhale Therapeutics Systems, Inc. | Storage of materials |
| US6586006B2 (en) | 1994-08-04 | 2003-07-01 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| US6589560B2 (en) | 1995-04-14 | 2003-07-08 | Nektar Therapeutics | Stable glassy state powder formulations |
| USRE38385E1 (en) | 1989-02-16 | 2004-01-13 | Nektar Therapeutics | Storage of materials |
| US6723497B2 (en) | 2000-02-10 | 2004-04-20 | The Regents Of The University Of California | Therapeutic platelets and methods |
| US6770478B2 (en) | 2000-02-10 | 2004-08-03 | The Regents Of The University Of California | Erythrocytic cells and method for preserving cells |
| AU2003287980B2 (en) * | 2002-11-01 | 2009-06-25 | Glaxosmithkline Biologicals S.A. | Drying process |
| ES2502691A1 (en) * | 2013-09-25 | 2014-10-03 | Sani-Red, S.L. | Method for preserving and stabilising proteins, which can be used for industrial development of formulations of sanitary, pharmaceutical and cosmetic products |
| US10559449B2 (en) | 2015-06-25 | 2020-02-11 | The Regents Of The University Of California | Stable support films for electron microscopy |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8715238D0 (en) * | 1987-06-29 | 1987-08-05 | Quadrant Bioresources Ltd | Food process |
| NZ309841A (en) * | 1995-06-07 | 1999-10-28 | Quadrant Holdings Cambridge | Methods for producing foamed glass matrices (fgm) and compositions obtained thereby |
| US6632648B1 (en) | 1996-05-14 | 2003-10-14 | Elan Drug Delivery Limited | Methods of terminal sterilization of fibrinogen |
| US6468782B1 (en) | 1996-12-05 | 2002-10-22 | Quadrant Healthcare (Uk) Limited | Methods of preserving prokaryotic cells and compositions obtained thereby |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| SI1458360T1 (en) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonary delivery of aminoglycosides |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1855591A (en) * | 1926-02-03 | 1932-04-26 | Wallerstein Co Inc | Invertase preparation and method of making the same |
| FR2532178A1 (en) * | 1982-08-31 | 1984-03-02 | Asahi Chemical Ind | PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME |
| EP0111216A2 (en) * | 1980-03-31 | 1984-06-20 | Takeda Chemical Industries, Ltd. | Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor |
| WO1986001103A1 (en) * | 1984-08-08 | 1986-02-27 | The Liposome Company, Inc. | Dehydrated liposomes |
| WO1986003938A1 (en) * | 1985-01-11 | 1986-07-17 | The Regents Of The University Of California | Method for preserving liposomes |
| WO1987000196A1 (en) * | 1985-07-09 | 1987-01-15 | Quadrant Bioresources Limited | Protection of proteins and the like |
-
1986
- 1986-02-28 GB GB868604983A patent/GB8604983D0/en active Pending
-
1987
- 1987-02-27 WO PCT/GB1987/000143 patent/WO1987005300A2/en not_active Application Discontinuation
- 1987-02-27 JP JP50150987A patent/JPS63502592A/en active Pending
- 1987-02-27 EP EP19870901561 patent/EP0259425A1/en not_active Withdrawn
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1855591A (en) * | 1926-02-03 | 1932-04-26 | Wallerstein Co Inc | Invertase preparation and method of making the same |
| EP0111216A2 (en) * | 1980-03-31 | 1984-06-20 | Takeda Chemical Industries, Ltd. | Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor |
| FR2532178A1 (en) * | 1982-08-31 | 1984-03-02 | Asahi Chemical Ind | PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME |
| WO1986001103A1 (en) * | 1984-08-08 | 1986-02-27 | The Liposome Company, Inc. | Dehydrated liposomes |
| WO1986003938A1 (en) * | 1985-01-11 | 1986-07-17 | The Regents Of The University Of California | Method for preserving liposomes |
| WO1987000196A1 (en) * | 1985-07-09 | 1987-01-15 | Quadrant Bioresources Limited | Protection of proteins and the like |
Non-Patent Citations (6)
| Title |
|---|
| Archives of Biochemistry and Biophysics", Volume 242, No. 1, October 1985, Academic Press, Inc. L.M. CROWE et al.: "Preservation of Freeze-Dried Liposomes by Trehalose", pages 240-247, see the whole document * |
| Biochemistry, Volume 24, 1985, American Chemical Society, (Washington, US), J. SZEBENI et al.: "Encapsulation of Hemoglobin in Phospholipid Liposomes: Characterization and Stability", pages 2827-2832, see pages 2827-2828 cited in the application * |
| CHEMICAL ABSTRACTS, Volume 103, No. 12, 23 September 1985, (Columbus, Ohio, US) T.D. MADDEN et al.: "Protection of Large Unilamellar Vesicles by Trehalose During Dehydration: Retention of Vesicle Contents", see page 316, Abstract 92759a, & Biochim. Biophys, Acta 198k, 817(1), 67-74 cited in the application * |
| CHEMICAL ABSTRACTS, Volume 85, No. 3, 19 July 1976, (Columbus, Ohio, US), P. LABRUDE et al.: "Lyophilization of Hemoglobin Solutions. Study of Protector Compounds Capable of Preventing the Formation of Methemoglobin", see page 415, Abstract 18011u, & J. Pharm. Belg. 1976, 31(2), 191-8 * |
| Science, Volume 223, No. 4637, 17 February 1984, American Association for the Advancement of Science, (Washington, US), J.H. CROWE et al.: "Preservation of Membranes in Anhydrobiotic Organisms: the role of Trehalose", pages 701-703, see the whole document cited in the application * |
| The Proceedings of Biotech '84 Europe, Volume 1, American Chemical Society "World Biotech Report 1984", pages 379-390, see pages 382-385 * |
Cited By (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149653A (en) * | 1988-01-21 | 1992-09-22 | Quadrant Bioresources Limited | Preservation of viruses |
| US5958670A (en) * | 1988-05-18 | 1999-09-28 | Cobe Laboratories, Inc. | Method of freezing cells and cell-like materials |
| US5648206A (en) * | 1988-08-26 | 1997-07-15 | Cobe Laboratories, Inc. | Lyophilization of cells |
| US5817334A (en) * | 1988-10-05 | 1998-10-06 | Nexstar Pharmaceuticals, Inc. | Method of making liposomes with improved stability during drying |
| WO1990004329A1 (en) * | 1988-10-20 | 1990-05-03 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
| US5059518A (en) * | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
| US5030560A (en) * | 1988-11-04 | 1991-07-09 | Immucor, Inc. | Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same |
| US5192663A (en) * | 1988-11-04 | 1993-03-09 | Immucor, Inc. | Article having an organic dye and a monolayer of dried mammalian cells and a method for utilizing the article |
| USRE39497E1 (en) | 1989-02-16 | 2007-02-27 | Nektar Therapeutics | Storage of materials |
| USRE37872E1 (en) | 1989-02-16 | 2002-10-08 | Inhale Therapeutics Systems, Inc. | Storage of materials |
| USRE38385E1 (en) | 1989-02-16 | 2004-01-13 | Nektar Therapeutics | Storage of materials |
| US5286629A (en) * | 1989-03-20 | 1994-02-15 | Parfums Christian Dior | Method of binding a product to the membrane of a keratinocyte by means of a ligand-receptor bond, method of preparing such a product, product obtained, cosmetic or pharmaceutical composition in which it is present and its method of preparation |
| WO1990011069A1 (en) * | 1989-03-20 | 1990-10-04 | Parfums Christian Dior | Process for the preparation of a ligand-receptor complex |
| FR2645741A1 (en) * | 1989-03-20 | 1990-10-19 | Dior Christian Parfums | METHOD FOR FIXING A PRODUCT ON THE MEMBRANE OF A KERATINOCYTE BY MEANS OF A LIGAND-RECEPTOR BOND, PROCESS FOR PREPARING SUCH A PRODUCT, OBTAINED PRODUCT, COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING THE SAME |
| EP0391444A3 (en) * | 1989-04-07 | 1992-03-04 | Syntex (U.S.A.) Inc. | Interleukin-1 formulation |
| EP0391444A2 (en) * | 1989-04-07 | 1990-10-10 | Syntex (U.S.A.) Inc. | Interleukin-1 Formulation |
| US5270057A (en) * | 1990-03-20 | 1993-12-14 | Akzo N.V. | Stabilized gonadotropin containing preparations |
| EP0448146A1 (en) * | 1990-03-20 | 1991-09-25 | Akzo Nobel N.V. | Stabilized gonadotropin containing preparations |
| US5384132A (en) * | 1990-03-20 | 1995-01-24 | Akzo N.V. | Stabilized gonadotropin containing preparations |
| EP0541556B1 (en) * | 1990-05-14 | 1998-09-16 | Quadrant Holdings Cambridge Limited | Stabilization of biological macromolecular substances and other organic compounds |
| US5641637A (en) * | 1991-01-11 | 1997-06-24 | Cobe Laboratories, Inc. | Method of preparing lyophilized and frozen cell standards |
| US6426210B1 (en) | 1991-06-26 | 2002-07-30 | Inhale Therapeutic Systems, Inc. | Storage of materials |
| US6825031B2 (en) | 1991-06-26 | 2004-11-30 | Nektar Therapeutics | Storage of materials |
| US5800978A (en) * | 1992-01-21 | 1998-09-01 | Cobe Laboratories, Inc. | Method of freezing cells and cell-like materials |
| WO1994019020A1 (en) * | 1993-02-23 | 1994-09-01 | Genentech, Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| US5753219A (en) * | 1993-02-23 | 1998-05-19 | Genentech, Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| US5804557A (en) * | 1993-02-23 | 1998-09-08 | Genentech, Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| EP0615747A1 (en) | 1993-03-18 | 1994-09-21 | Terumo Kabushiki Kaisha | Hemoglobin-encapsulating liposome and method for making the same |
| US5688526A (en) * | 1993-03-18 | 1997-11-18 | Terumo Kabushiki Kaisha | Hemoglobin-encapsulating liposome and method for making the same |
| EP0687463A1 (en) * | 1994-06-15 | 1995-12-20 | Terumo Kabushiki Kaisha | Hemoglobin-encapsulated liposome |
| US5674528A (en) * | 1994-06-15 | 1997-10-07 | Terumo Kabushiki Kaisha | Hemoglobin-encapsulated liposome |
| US6586006B2 (en) | 1994-08-04 | 2003-07-01 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| US6893657B2 (en) | 1994-12-02 | 2005-05-17 | Quadrant Drug Delivery Ltd. | Solid dose delivery vehicle and methods of making same |
| US6811792B2 (en) | 1994-12-02 | 2004-11-02 | Quadrant Drug Delivery Ltd. | Solid dose delivery vehicle and methods of making same |
| US7056495B2 (en) | 1994-12-02 | 2006-06-06 | Quadrant Drug Delivery Ltd. | Solid dose delivery vehicle and methods of making same |
| US6565871B2 (en) | 1994-12-02 | 2003-05-20 | Elan Drug Delivery Ltd. | Solid dose delivery vehicle and methods of making same |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| US6331310B1 (en) | 1994-12-02 | 2001-12-18 | Quadrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| US6589560B2 (en) | 1995-04-14 | 2003-07-08 | Nektar Therapeutics | Stable glassy state powder formulations |
| US6071428A (en) * | 1995-04-28 | 2000-06-06 | Inhale Therapeutic Systems | Stable compositions |
| US6503411B1 (en) | 1995-04-28 | 2003-01-07 | Inhale Therapeutic Systems, Inc. | Stable compositions |
| US6221575B1 (en) | 1997-02-07 | 2001-04-24 | Quadrant Holdings Cambridge Ltd. | Methods for producing dried storage-stable platelets and compositions obtained thereby |
| AU732274B2 (en) * | 1997-02-07 | 2001-04-12 | Quadrant Drug Delivery Limited | Methods and compositions for producing dried, storage-stable platelets |
| WO1998034478A1 (en) * | 1997-02-07 | 1998-08-13 | Quadrant Holdings Cambridge Limited | Methods and compositions for producing dried, storage-stable platelets |
| US6723497B2 (en) | 2000-02-10 | 2004-04-20 | The Regents Of The University Of California | Therapeutic platelets and methods |
| US6770478B2 (en) | 2000-02-10 | 2004-08-03 | The Regents Of The University Of California | Erythrocytic cells and method for preserving cells |
| AU2003287980B2 (en) * | 2002-11-01 | 2009-06-25 | Glaxosmithkline Biologicals S.A. | Drying process |
| ES2502691A1 (en) * | 2013-09-25 | 2014-10-03 | Sani-Red, S.L. | Method for preserving and stabilising proteins, which can be used for industrial development of formulations of sanitary, pharmaceutical and cosmetic products |
| WO2015011308A1 (en) * | 2013-09-25 | 2015-01-29 | Sani-Red, S.L. | Method for preserving and stabilising proteins, which can be used for industrial development of formulations of sanitary, pharmaceutical and cosmetic products |
| EP4241783A1 (en) * | 2013-09-25 | 2023-09-13 | Sani-Red, S.L. | Method for preserving and stabilising proteins, which can be used for industrial development of formulations of sanitary, pharmaceutical and cosmetic products |
| US10559449B2 (en) | 2015-06-25 | 2020-02-11 | The Regents Of The University Of California | Stable support films for electron microscopy |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0259425A1 (en) | 1988-03-16 |
| JPS63502592A (en) | 1988-09-29 |
| GB8604983D0 (en) | 1986-04-09 |
| WO1987005300A3 (en) | 1987-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1987005300A2 (en) | Protein preservation | |
| CA1197462A (en) | Functional oxygen transport system | |
| JP2809735B2 (en) | Lyophilization of cells | |
| US5242792A (en) | Method for the preservation of red blood cells by lyophilization using glycerol or inositol with disaccharides | |
| Crowe et al. | Stabilization of dry phospholipid bilayers and proteins by sugars. | |
| US4806343A (en) | Cryogenic protectant for proteins | |
| US4874690A (en) | Lyophilization of red blood cells | |
| US5178884A (en) | Lyophilized and reconstituted red blood cell compositions | |
| KR920002300B1 (en) | Method for preserving liposomes | |
| Newman et al. | The role of trehalose and other carbohydrates in biopreservation | |
| IE47165B1 (en) | Process for the dehydration of a colloidal dispersion of liposomes | |
| US4897353A (en) | Cryogenic protection of phosphofructokinase using amino acids and zinc ions | |
| Török et al. | Preservation of trehalose-loaded red blood cells by lyophilization | |
| Tan et al. | Freeze-drying of fungi: influence of composition and glass transition temperature of the protectant | |
| ES2210481T3 (en) | THERMOSTABILIZATION, OSMOPROTECTION AND PROTECTION AGAINST THE DESECTION OF ENZYMES, CELL COMPONENTS AND CELLS THROUGH MANOSILGLYCERATE. | |
| Yoshikawa et al. | Extraction of trehalose from thermally-treated bakers’ yeast | |
| CN102327289B (en) | Erythrocyte freeze-dried powder preparation for injection and preparation method thereof | |
| US4612370A (en) | Lipid-saccharide reaction products | |
| WO1992008478A1 (en) | Method of enhancing long-term storage stability of hemoglobin products | |
| Johnston et al. | The influence of sugars on the properties of freeze-dried lysozyme and haemoglobin | |
| HANDA et al. | Lyophilized liposomes prepared by a modified reversed-phase evaporation method | |
| US5071660A (en) | Process utilizing alcohol oxidase | |
| JPH02178233A (en) | Liposome containing hemoglobin and preparation thereof | |
| JP3194050B2 (en) | Method for producing powdered hemoglobin | |
| NEWMAN et al. | Carbohydrates in Biopreservation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1987901561 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 1987901561 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1987901561 Country of ref document: EP |